NCT04788914View on ClinicalTrials.gov

lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 21, 2020

Primary Completion Date

December 30, 2024

Study Completion Date

July 31, 2025

Conditions
CKDPAD
Interventions
DIETARY_SUPPLEMENT

Active bamboo charcoal± probiotics

Active bamboo charcoal 2g, TID probiotics 0.8g

Trial Locations (1)

Unknown

RECRUITING

NTUH, Taipei, Taiwan

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER